William F. Doyle, Executive Chairman of NovoCure Ltd ($NVCR), made two open market stock sales in the last year totaling $933 thousand. His most recent NVCR insider sale occurred on March 3, 2026. These transactions rank 5,088th among 11,678 insiders by sale value, well below the average of 8.6 million dollars across 6.4 transactions per insider. Doyle reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | NovoCure Ltd | $NVCR | DOYLE WILLIAM F | Executive Chairman | A | Stock Option (Right to Buy) | 30072 | $0.00 | 288,517.0000 | 111,981,981 | 11.64% | 0.03% |
| March 3, 2026 | NovoCure Ltd | $NVCR | DOYLE WILLIAM F | Executive Chairman | A | Ordinary Shares | 200000 | $0.00 | 200,000.0000 | 111,981,981 | 9999.99% | 0.18% |
| March 3, 2026 | NovoCure Ltd | $NVCR | DOYLE WILLIAM F | Executive Chairman | A | Ordinary Shares | 200284 | $0.00 | 400,284.0000 | 111,981,981 | 100.14% | 0.18% |
| March 3, 2026 | NovoCure Ltd | $NVCR | DOYLE WILLIAM F | Executive Chairman | S | Ordinary Shares | 50557 | $12.79 | 349,727.0000 | 111,981,981 | 12.63% | 0.05% |
| March 3, 2026 | NovoCure Ltd | $NVCR | DOYLE WILLIAM F | Executive Chairman | S | Ordinary Shares | 21330 | $13.43 | 328,397.0000 | 111,981,981 | 6.10% | 0.02% |
| March 3, 2026 | NovoCure Ltd | $NVCR | DOYLE WILLIAM F | Executive Chairman | A | Stock Option (Right to Buy) | 258445 | $0.00 | 258,445.0000 | 111,981,981 | 9999.99% | 0.23% |
| May 29, 2025 | PROKIDNEY CORP. | $PROK | DOYLE WILLIAM F | Not found | A | Director stock option (right to buy) | 125862 | $0.00 | 125,862.0000 | 163,693,707 | 9999.99% | 0.08% |
| Nov. 29, 2024 | Elanco Animal Health Inc | $ELAN | DOYLE WILLIAM F | Not found | A | Common Stock | 18169 | $0.00 | 94,499.0000 | 497,700,000 | 23.80% | 0.00% |
| May 30, 2024 | PROKIDNEY CORP. | $PROK | DOYLE WILLIAM F | Not found | A | Director stock option (right to buy) | 62558 | $0.00 | 62,558.0000 | 168,297,916 | 9999.99% | 0.04% |
| May 21, 2024 | Elanco Animal Health Inc | $ELAN | DOYLE WILLIAM F | Not found | P | Common Stock | 15000 | $16.98 | 76,330.0000 | 492,300,000 | 24.46% | 0.00% |
| March 8, 2024 | Elanco Animal Health Inc | $ELAN | DOYLE WILLIAM F | Not found | P | Common Stock | 15000 | $16.30 | 61,330.0000 | 492,300,000 | 32.38% | 0.00% |
| June 29, 2023 | PROKIDNEY CORP. | $PROK | DOYLE WILLIAM F | Director | A | Director Stock Option (right to buy) | 48128 | $0.00 | 48,128.0000 | 171,578,320 | 9999.99% | 0.03% |